The European Patent Office published patent EP3485405A1 on March 25, 2026, covering a drug dosing recommendation system. Fresenius Medical Care Deutschland GmbH filed the application, with inventors Carlo Barbieri and Flavio Mari. The patent is classified under G16H 20/10 (Health Informatics - Therapies) and designates 35 European and extension states including all EU member states.

Healthcare providers and pharmaceutical companies should review the patent claims to assess potential licensing needs or freedom-to-operate considerations for drug dosing systems. This patent publication establishes priority date and begins the examination period; third parties may file observations during the opposition period.